TRANSTEC

This brand name is authorized in Austria, Brazil, Croatia, Ecuador, Germany, Ireland, Mexico, Netherlands, Poland, Spain, UK.

Active ingredients

The drug TRANSTEC contains one active pharmaceutical ingredient (API):

1	Buprenorphine UNII 40D3SCR4GZ - BUPRENORPHINE
	Buprenorphine is an opioid partial agonist/antagonist which attaches itself to the μ (mu) and κ (kappa) receptors of the brain. Its activity in opioid maintenance treatment is attributed to its slowly reversible link with the μ receptors which, over a prolonged period, minimises the need of illicit opioids for patients with opioid dependence.
	Read more about Buprenorphine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TRANSTEC Transdermal patch	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AE01	Buprenorphine	N Nervous system → N02 Analgesics → N02A Opioids → N02AE Oripavine derivatives
Discover more medicines within N02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	542818120002304, 542818120002404, 542818120002504, 542818120002604, 542818120002704, 542818120002804, 542818120002904, 542818120003004, 542818120003104
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00082392, 00082417, 00082446, 00082452, 00082469, 00082475, 00082481, 00082535, 00082564, 00082570, 00082587, 00082593, 00082647, 00082653, 00082676, 02514683, 02515518, 02515903, 04187426, 04187432, 04187449, 04187478, 04187484, 04187490, 04187521, 04187538, 04187544, 04336808, 04362361, 04386315, 05891630, 05891647, 05891699, 05891713, 05891742, 05891765, 06322354, 06322360, 06322526, 06322532, 06323632, 06323649, 06324146, 06324471, 06324695, 06325051, 06325536, 06325542, 09235584, 09235590, 09235609, 09235615, 09235621, 09235638, 09235644, 09235650, 09235667, 09235673, 09235696, 09235704, 09287919, 09287931, 09287954, 09287960, 09287977, 09287983, 09673195, 09673226, 09673249, 10515975, 10515981, 10515998, 10516006, 10516064, 10516070, 10516087, 10516124, 10516130, 10516147, 11148651, 11148668, 11148680, 11148734, 11148757, 11148786, 16391304, 16391310
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.192-02-05, 26.193-02-05, 26.194-02-05
ES	Centro de información online de medicamentos de la AEMPS	64684, 64685, 64686
GB	Medicines & Healthcare Products Regulatory Agency	103670, 103674, 103688, 140089, 140092, 140098, 146750, 146752, 146839, 180684, 180687, 180689, 373749, 373751, 373753
HR	Agencija za lijekove i medicinske proizvode	HR-H-025230904, HR-H-479705231, HR-H-906948213
IE	Health Products Regulatory Authority	32134, 38436, 42461, 42473, 42484, 42719
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	289M2006
NL	Z-Index G-Standaard, PRK	76643, 76651, 76678
PL	Rejestru Produktów Leczniczych	100110990, 100111009, 100111015